ROWASA 250 mg, gastro-resistant coated tablet 90 tablets
Active ingredients: Mesalazine
Commercialized according to BDPMDispensing in France: Prescription only
Gastro-resistant coated tablet90 tabletsorale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- ROWASA 250 mg, comprimé enrobé gastro-résistant
- Pharmaceutical form
- comprimé enrobé gastro-résistant(e)
- Route of administration
- orale
- Presentation description
- plaquette(s) PVDC aluminium PVC de 90 comprimé(s)
- Marketing authorisation holder
- TEOFARMA
- Reimbursement according to BDPM
- 65%
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 19 May 1993
- Prescription and dispensing conditions
- Prescription only
- List II: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
63599339CIP73338254CIP133400933382544Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| MÉSALAZINEcomprimé | 250 mg · un comprimé | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.